Opinion
Video
The panel discuss if including biosimilars on formulary at parity is enough to support their adoption.
Video content above is prompted by the following:
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831
© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.